$20.39 +0.42 (2.10%) Retrophin Inc - NASDAQ

Dec. 5, 2016 | 03:39 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 20.39
Trade Time: Dec 05 03:39 PM Eastern Daylight Time
Change: +0.42 (2.10%)
Prev Close: 19.97
Open: 19.94
Bid: 20.35
Ask: 20.40
  1. No results found.
  1. Shkreli Faces Fraud Charges

    IBD | Dec. 17, 2015 | 18:30PM EST
  2. KaloBios CEO Shkreli Arrested For Securities Fraud

    IBD | Dec. 17, 2015 | 11:43AM EST
  3. Shrkeli, Drug Price Gauging CEO, Charged With Fraud

    FoxBusiness | Dec. 17, 2015 | 06:55AM EST
  4. Panel seeks drug-pricing info

    IBD | Nov. 4, 2015 | 18:31PM EST
  5. Senate Probes Valeant, Turing Over Price-Gouging

    IBD | Nov. 4, 2015 | 17:04PM EST
  6. Collins, McCaskill Open Senate Investigation into Rx Drug Pricing, Announce Intention to Hold Hearings

    Benzinga | Nov. 4, 2015 | 08:17AM EST
  7. Benzinga's Top Initiations

    Benzinga | Nov. 2, 2015 | 09:36AM EST
  8. Retrophin At All-Time High Levels on RE-024 FDA-Status; Syneron Settles Legal Battle

    GuruFocus | Jun. 5, 2015 | 11:40AM EST
  9. Retrophin Receives Fast Track Designation for RE-024 for the Treatment of Pantothenate Kinase-Associated Neurodegeneration

    Benzinga | Jun. 4, 2015 | 15:46PM EST
  10. Benzinga's Top Initiations

    Benzinga | Apr. 28, 2015 | 10:30AM EST
  11. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Retrophin, ...

    GuruFocus | Nov. 28, 2014 | 11:03AM EST
  12. Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Retrophin, Inc.

    GuruFocus | Oct. 24, 2014 | 15:03PM EST
  13. Retrophin Announces Appointment Of Jeffrey A. Meckler To Board Of Directors

    Benzinga | Oct. 10, 2014 | 07:00AM EST
  14. Retrophin Announces Appointment Of Gary Lyons To Board Of Directors

    Benzinga | Oct. 9, 2014 | 07:02AM EST
  15. Morning Market Losers

    Benzinga | Sep. 17, 2014 | 08:48AM EST
Trading Center